Your browser doesn't support javascript.
loading
The efficacy and safety of fingolimod in patients with relapsing multiple sclerosis: A meta-analysis.
Yang, Ting; Tian, Xin; Chen, Chao-Yang; Ma, Ling-Yun; Zhou, Shuang; Li, Min; Wu, Ye; Zhou, Ying; Cui, Yi-Min.
Afiliação
  • Yang T; Department of Pharmacy, Peking University First Hospital, Beijing, China.
  • Tian X; Department of Pharmacy, Peking University First Hospital, Beijing, China.
  • Chen CY; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing, China.
  • Ma LY; Department of Pharmacy, Peking University First Hospital, Beijing, China.
  • Zhou S; Department of Pharmacy, Peking University First Hospital, Beijing, China.
  • Li M; Department of Pharmacy, Peking University First Hospital, Beijing, China.
  • Wu Y; Department of Pharmacy, Peking University First Hospital, Beijing, China.
  • Zhou Y; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing, China.
  • Cui YM; Department of Pediatrics, Peking University First Hospital, Beijing, China.
Br J Clin Pharmacol ; 86(4): 637-645, 2020 04.
Article em En | MEDLINE | ID: mdl-31869429
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Esclerose Múltipla Tipo de estudo: Clinical_trials / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Esclerose Múltipla Tipo de estudo: Clinical_trials / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article